 Andrea Newsome
Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pharmacy Service, Hospital | 6 | 2022 | 89 | 3.530 |
Why?
| | Critical Illness | 10 | 2022 | 900 | 3.010 |
Why?
| | Shock, Septic | 5 | 2021 | 227 | 2.340 |
Why?
| | Pharmacists | 9 | 2022 | 258 | 2.180 |
Why?
| | Intensive Care Units | 11 | 2025 | 924 | 2.050 |
Why?
| | Pharmacy | 3 | 2021 | 32 | 1.470 |
Why?
| | Mentors | 2 | 2021 | 217 | 1.130 |
Why?
| | Critical Care | 8 | 2021 | 702 | 1.100 |
Why?
| | Medication Therapy Management | 2 | 2025 | 72 | 0.980 |
Why?
| | Pharmaceutical Services | 3 | 2021 | 76 | 0.860 |
Why?
| | Education, Pharmacy | 3 | 2020 | 120 | 0.840 |
Why?
| | Norepinephrine | 2 | 2021 | 201 | 0.780 |
Why?
| | Students, Pharmacy | 3 | 2020 | 96 | 0.760 |
Why?
| | Community Pharmacy Services | 1 | 2021 | 46 | 0.670 |
Why?
| | Peptic Ulcer | 1 | 2020 | 18 | 0.650 |
Why?
| | Medication Reconciliation | 1 | 2020 | 32 | 0.640 |
Why?
| | APACHE | 1 | 2020 | 68 | 0.640 |
Why?
| | Hypotension | 1 | 2021 | 127 | 0.620 |
Why?
| | Vasoconstrictor Agents | 4 | 2021 | 150 | 0.610 |
Why?
| | Sepsis | 3 | 2020 | 664 | 0.580 |
Why?
| | Drug Therapy | 1 | 2019 | 84 | 0.560 |
Why?
| | Anesthesia | 1 | 2021 | 257 | 0.530 |
Why?
| | Mentoring | 1 | 2020 | 166 | 0.510 |
Why?
| | Fluid Therapy | 5 | 2021 | 155 | 0.500 |
Why?
| | Machine Learning | 1 | 2020 | 587 | 0.420 |
Why?
| | Electronic Health Records | 1 | 2022 | 1202 | 0.400 |
Why?
| | Patient Care Team | 1 | 2019 | 697 | 0.400 |
Why?
| | Humans | 35 | 2025 | 145783 | 0.390 |
Why?
| | Heart-Assist Devices | 1 | 2019 | 568 | 0.370 |
Why?
| | Analgesics, Opioid | 1 | 2021 | 1154 | 0.370 |
Why?
| | Matrix Metalloproteinase 3 | 3 | 2021 | 27 | 0.360 |
Why?
| | Decision Support Systems, Clinical | 1 | 2025 | 273 | 0.340 |
Why?
| | Hospital Mortality | 3 | 2020 | 1038 | 0.320 |
Why?
| | Artificial Intelligence | 1 | 2025 | 381 | 0.320 |
Why?
| | Heart Failure | 2 | 2020 | 2326 | 0.300 |
Why?
| | Professional Role | 2 | 2021 | 170 | 0.290 |
Why?
| | Retrospective Studies | 8 | 2024 | 17330 | 0.280 |
Why?
| | Enterococcus faecalis | 1 | 2024 | 29 | 0.210 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2024 | 72 | 0.200 |
Why?
| | Patient Discharge | 2 | 2020 | 995 | 0.190 |
Why?
| | Bacteremia | 1 | 2024 | 222 | 0.170 |
Why?
| | Sexual Harassment | 1 | 2021 | 29 | 0.170 |
Why?
| | Pharmacies | 1 | 2021 | 40 | 0.170 |
Why?
| | Claudin-5 | 1 | 2021 | 3 | 0.170 |
Why?
| | Atracurium | 1 | 2021 | 14 | 0.170 |
Why?
| | Adult | 8 | 2025 | 40881 | 0.170 |
Why?
| | Water-Electrolyte Balance | 1 | 2021 | 37 | 0.170 |
Why?
| | Vasopressins | 1 | 2021 | 61 | 0.160 |
Why?
| | Faculty, Pharmacy | 1 | 2020 | 20 | 0.160 |
Why?
| | Hospitalization | 2 | 2021 | 2461 | 0.160 |
Why?
| | Angiotensin II | 1 | 2020 | 102 | 0.160 |
Why?
| | Efficiency | 1 | 2020 | 103 | 0.150 |
Why?
| | Microvessels | 1 | 2021 | 97 | 0.150 |
Why?
| | Faculty | 1 | 2020 | 148 | 0.150 |
Why?
| | Shock | 1 | 2020 | 110 | 0.150 |
Why?
| | Cadherins | 1 | 2021 | 201 | 0.150 |
Why?
| | Resource Allocation | 1 | 2019 | 52 | 0.150 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2019 | 25 | 0.140 |
Why?
| | Academic Medical Centers | 1 | 2022 | 554 | 0.140 |
Why?
| | Models, Organizational | 1 | 2019 | 144 | 0.140 |
Why?
| | Laryngeal Edema | 1 | 2018 | 1 | 0.140 |
Why?
| | Bayes Theorem | 1 | 2020 | 421 | 0.140 |
Why?
| | Patient Care | 1 | 2019 | 120 | 0.140 |
Why?
| | Meta-Analysis as Topic | 1 | 2019 | 173 | 0.140 |
Why?
| | Adenosine Monophosphate | 1 | 2019 | 85 | 0.140 |
Why?
| | Polypharmacy | 1 | 2019 | 94 | 0.130 |
Why?
| | Length of Stay | 2 | 2024 | 1350 | 0.130 |
Why?
| | Delirium | 1 | 2019 | 105 | 0.130 |
Why?
| | Postoperative Hemorrhage | 1 | 2019 | 105 | 0.130 |
Why?
| | Antigens, CD | 1 | 2021 | 558 | 0.130 |
Why?
| | Minocycline | 1 | 2017 | 23 | 0.130 |
Why?
| | Ventricular Function, Left | 1 | 2021 | 544 | 0.130 |
Why?
| | Airway Extubation | 1 | 2018 | 60 | 0.130 |
Why?
| | Lipopolysaccharides | 1 | 2021 | 858 | 0.130 |
Why?
| | Heparin | 1 | 2019 | 247 | 0.130 |
Why?
| | Interprofessional Relations | 1 | 2020 | 276 | 0.130 |
Why?
| | Resuscitation | 1 | 2020 | 312 | 0.130 |
Why?
| | Blood Pressure | 2 | 2021 | 1782 | 0.130 |
Why?
| | Blood Coagulation | 1 | 2019 | 274 | 0.120 |
Why?
| | Enteral Nutrition | 1 | 2019 | 217 | 0.120 |
Why?
| | Cooperative Behavior | 1 | 2020 | 463 | 0.120 |
Why?
| | Research | 1 | 2020 | 431 | 0.120 |
Why?
| | Cerebral Hemorrhage | 1 | 2017 | 125 | 0.120 |
Why?
| | Periodicals as Topic | 1 | 2019 | 209 | 0.120 |
Why?
| | Perioperative Care | 1 | 2019 | 231 | 0.120 |
Why?
| | Neuroprotective Agents | 1 | 2017 | 148 | 0.120 |
Why?
| | Brain Ischemia | 1 | 2019 | 359 | 0.110 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2019 | 499 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2021 | 956 | 0.100 |
Why?
| | Practice Guidelines as Topic | 2 | 2019 | 1582 | 0.100 |
Why?
| | Pain | 1 | 2019 | 791 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2024 | 1925 | 0.100 |
Why?
| | Research Design | 1 | 2019 | 1139 | 0.100 |
Why?
| | Anticoagulants | 1 | 2019 | 748 | 0.100 |
Why?
| | Treatment Outcome | 4 | 2024 | 11794 | 0.090 |
Why?
| | Aged | 3 | 2024 | 26217 | 0.090 |
Why?
| | Middle Aged | 4 | 2024 | 36309 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2933 | 0.080 |
Why?
| | Administration, Intravenous | 2 | 2024 | 172 | 0.080 |
Why?
| | Stroke | 1 | 2019 | 1271 | 0.080 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8347 | 0.070 |
Why?
| | Male | 5 | 2024 | 73010 | 0.060 |
Why?
| | Educational Measurement | 2 | 2020 | 326 | 0.060 |
Why?
| | Female | 4 | 2024 | 79045 | 0.050 |
Why?
| | Respiration, Artificial | 2 | 2019 | 714 | 0.050 |
Why?
| | Curriculum | 2 | 2020 | 1074 | 0.050 |
Why?
| | Administration, Oral | 1 | 2024 | 867 | 0.040 |
Why?
| | Gender Identity | 1 | 2021 | 129 | 0.040 |
Why?
| | Georgia | 1 | 2020 | 79 | 0.040 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2019 | 30 | 0.040 |
Why?
| | Biomarkers | 2 | 2021 | 4302 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 2019 | 197 | 0.040 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2020 | 376 | 0.030 |
Why?
| | Patient Readmission | 1 | 2024 | 773 | 0.030 |
Why?
| | Respiratory Sounds | 1 | 2018 | 103 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2020 | 507 | 0.030 |
Why?
| | Acute Lung Injury | 1 | 2020 | 307 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1478 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 1036 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 6033 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2021 | 4151 | 0.020 |
Why?
| | Mice | 2 | 2021 | 18355 | 0.020 |
Why?
| | Rats | 1 | 2020 | 5585 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 6085 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2884 | 0.020 |
Why?
| | Animals | 2 | 2021 | 38101 | 0.020 |
Why?
| | United States | 1 | 2018 | 16126 | 0.010 |
Why?
|
|
Newsome's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|